<DOC>
	<DOC>NCT03072979</DOC>
	<brief_summary>Pre-clinical evidence suggests that radiotherapy reduces tumour-associated vasculature. The investigators will conduct a single-arm prospective study to quantify the reduction in tumour vasculature post-radiotherapy</brief_summary>
	<brief_title>A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Age â‰¥21 years of age Proven metastatic disease, excluding haematological and germ cell neoplasms Life expectancy &gt;3 months, Eastern Cooperative Oncology group (ECOG) 02 The patient must not have an allergy to gadolinium contrast that will limit the ability to image the tumour by MRI safely even with the use of premedication eGFR &lt; 30 mL/min or if patient is suffering from acute renal insufficiency Prior radiotherapy to the specified region Recent surgery to affected spinal levels, or patients requiring immediate surgical intervention Spinal instability score (SINS) &gt;12 Symptomatic cord compression (Bilksy grade 2 or 3), or worsening neurological deficits Body weight of more than 120kg Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>